Stephen Hahn, commissioner of the Food and Drug Administration, told CBS News only science and data will determine when a vaccine is available. According to a poll by the Kaiser Family Foundation published september 10, a majority of US adults, 62%, said they're anxious that that pressure from the White House could lead the FDA to approve a vaccine before it's determined to be safe and effective.
Russian Federation is now completing work on a new mobile application that would enable direct contact between patients and the vaccine developers, Murashko said, praising it as "the first experience of this kind in the world".
Three-quarters of Republicans and one-quarter of Democrats have at least one misconception, compared to 46% of people who identify as independents, KFF reported.
62% said they worry that political pressure from the Trump administration would force the FDA to rush the vaccine development and rollout before ensuring its safety and efficacy.
Another 36% in the poll say they aren't concerned that influence from Republican President Donald Trump's administration will lead to approval before a vaccine is ready. Beyond the 190,000 Americans - and 900,000 people in all worldwide - that COVID-19 has killed, the virus' toll on the economy and on mental health are huge.
Adams also called on Congress members to set an example to Americans by staying up to date on all vaccinations, further advising them to spread the message that vaccines are safe in any ways they can. More people getting vaccinated would be especially necessary if the approved vaccination can only provide only limited immunity, and the FDA has signaled that it would approve a vaccine if it prevents disease or makes the illness less severe in as few as 50% of people. One in 5 said "wearing a face mask is harmful to your health" and 1 in 4 believe hydroxychloroquine, a drug widely touted by Trump and shown in studies to be unhelpful in treating coronavirus, is effective.
In this file picture taken on March 26, 2020 a researcher works on the diagnosis of suspected coronavirus COVID-19 cases in Belo Horizonte, state of Minas Gerais, Brazil.
Some drug makers are already at phase three trials like Moderna, Pfizer and AstraZeneca.
The notice was issued following reports that human trials of the Covid-19 vaccine candidate being developed by the University of Oxford have been put on hold after a British participant had an adverse reaction to it, reports NDTV.